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Introduction
Australia enjoys a high international
reputation for research in experimental
genetics, molecular and cell biology,
animal and plant sciences, biotechnology,
medicine, biodiversity, and ecological
modelling. Computational research is
broadly established in these domain areas
and others relevant to bioscience. Com-
bined with strong traditions in mathemat-
ics and statistics, and national and state
investment in computational infrastruc-
ture, computational biology Down Under
is simply too rich and diverse to be done
justice in these few pages. Here we (see
Box 1 Authors’ Biographies) focus more
narrowly, attempting to provide a snap-
shot of bioinformatic and computational
genome-scale biology in Australia circa
2008.
Origins: Platforms and Policies
Areas within computational bioscience
have been strongly established for several
decades in Australia, i.e., the modelling of
natural resource utilisation, ecosystem
dynamics, and protein structures. Austra-
lia was not, however, a significant partner
in the international genome mapping and
sequencing consortia of the 1990s, and a
review of bioinformatics in Australia
published by one of us in 2000 [1] did
not mention any research projects in
genomic biology. The Australian Genome
Research Facility (AGRF) was established
in 1997 as part of the Federal Govern-
ment’s Major National Research Facilities
(MNRF) program and offered DNA li-
brary preparation, automated fluorescent
sequencing, and first-stage bioinformatic
services. There was never a national
genomics program, funding body, or
educational or training initiative; the first
two organismal genomes sequenced do-
mestically, two strains of Leptospira borgpe-
tersenii [2], were published only in 2006.
Most Australian involvement in genomic
sequencing has been, and remains, via
collaboration with groups overseas, e.g.,
the United States Department of Energy’s
Joint Genome Institute, Baylor College of
Medicine, and RIKEN Genomic Sciences
Center.
Building on strength in underlying
biological and biomedical research, Aus-
tralia was more proactive in functional
genomics, i.e., transcriptomics, proteo-
mics, and genotype–phenotype association
studies. Expression-array platforms were
installed at AGRF, the Commonwealth
Scientific and Industrial Research Orga-
nisation (CSIRO), and a number of
universities and medical research insti-
tutes. Leading statisticians in universities
and CSIRO took on the high-dimensional
problems posed by expression array data.
The word proteome was coined in 1994
by Marc Wilkins, then a PhD student at
The University of Sydney [3]. Proteomics
developed around mass spectrometry and
separation platforms, with activity at
Macquarie University in Sydney giving
rise in 1995 to the MNRF Australian
Proteome Analysis Facility (APAF), and in
1999 to the for-profit company Proteome
Systems Ltd [4]. Like AGRF, APAF was
developed with several specialist nodes
located in different Australian capital
cities.
In 2000, Australian bioinformatics (spe-
cifically ANGIS, the Australian National
Genome Information Service) was seen to
be a world leader in bioinformatics service
provision [1]. With Internet connectivity
to the National Center for Biotechnology
Information (NCBI) or European Bioin-
formatics Institute (EBI) slow and expen-
sive, ANGIS—founded by one of us (TL)
at The University of Sydney in 1990—
provided an innovative service delivery
model based on local data mirrors, user-
friendly portals, nodes in major cities, and
a national training program. University
departments as a whole, as well as
individual researchers from academia,
the public sector, and private industry,
subscribed to the ANGIS service, and it
was used intensively for molecular biology
and bioinformatics education across Aus-
tralia. ANGIS was a founding member of
Asia-Pacific BioNet, formed in 1998 based
on the EMBNet model of distributed data
and computational resources embedded
with major user communities [1], and
itself served as a model for the Canadian
Bioinformatics Resource. A BioMirror site
was established at the Australian National
University (ANU) in coordination with the
Australian Partnership in Advanced Com-
puting (APAC) to provide data, but was
not intended to offer analysis or querying
functionality to biologists.
Beginning in 1998, high-performance
computing in Australia was organised
through APAC and its eight partners
(one in each state of Australia, one in the
national capital Canberra, and one in
CSIRO). Researchers accessed the APAC
national supercomputing facility and most
partner facilities via a semiannual peer-
reviewed application scheme which con-
tinues, with improvements, to the present.
APAC also operated support and outreach
programs in advanced computing, and
from 2004 instituted discipline-based pro-
jects, including one in bioinformatics, to
build familiarity with grid technologies
within communities and to trial common
solutions.
This background sets the stage for our
description of bioinformatic and compu-
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in 2008. While the focus of this paper is
science, we must first refer to the policy
framework that, perhaps more keenly now
than at most other points in recent history,
is shaping Australian computational bio-
science. Beginning in 2000, a series of
high-level discussion papers, government
reports, and strategy documents [5–12]
considered how to strengthen and provide
cohesion to Australia’s bioinformatics ef-
fort. These culminated in a 2005 national
bioinformatics strategy [13] that forms
part of the national biotechnology strate-
gy. The bioinformatics strategy document
made 41 ‘‘key findings’’ and proposed
recommendations in infrastructure, re-
search and development, education and
training, commercialisation, data manage-
ment, and coordination. In a parallel
initiative, in 2004 two Federal Govern-
ment ministries jointly constituted the
national e-Research Coordinating Com-
mittee to make recommendations on how
best to facilitate the application of infor-
mation and communication technologies
(ICT) across Australian R&D [14]. Also in
2004, following on from earlier recom-
mendations [5], the Federal Government
implemented a top-down strategic infra-
structure funding process in fifteen identi-
fied capability areas including ‘‘evolving
bio-molecular platforms and informatics’’
[15]. Together with co-investment by the
States and CSIRO, this National Collab-
orative Research Infrastructure Strategy
(NCRIS) will allocate more than AUD
1 billion from early 2007 through mid
2011. National support for AGRF (geno-
mics), APAF (proteomics), and APAC
(advanced computing) is being subsumed
under NCRIS, and new capabilities are
being funded. In early 2008 the structural
changes implemented through NCRIS are
beginning to impact Australian research
communities, including those involved in
bioinformatics and computational ge-
nome-scale biology.
Computational Biology
Research in Australia: Centres
and Programs
One readily apparent change to the face
of Australian research since the Millenni-
um has been the advent of large integrated
bioscience institutes and centres with
significant computational and/or infor-
matic focus. Some of these are centralised
physical centres (e.g., the first three
described below); others exist within a
geographically distributed organisation,
and some are virtual centres involving
multiple organisations.
The Bio21 Institute, established in
Melbourne in 2000, is a joint initiative of
20 universities, institutes, hospitals, and
centres in the state of Victoria founded by
Melbourne Health (MH), the University of
Melbourne, and the Walter and Eliza Hall
Institute of Medical Research (WEHI).
Bio21 aims to build synergies in biomed-
ical research and biotechnology based on
shared technologies (proteomics, protein
structure determination, high-throughput
chemical screening, metabolomics, infor-
matics), business development, and train-
ing initiatives. Bio21 has a major bioinfor-
matics research component that is being
integrated with human clinical data. One
initiative is the informatics platform
MMIM (Molecular Medicine Informatics
Model), which integrates clinical, patient
outcome, and genomic data across eight of
the partners, including a major healthcare
provider (MH), three hospitals, two re-
search institutes (WEHI, and the Ludwig
Institute for Cancer Research), and a
clinical trials network (Cancer Trials
Australia). Six further healthcare sites are
expected to join MMIM by the end of
2009 (see Box 2).
Also established in 2000, the Institute for
Molecular Bioscience (IMB) of The Uni-
versity of Queensland, in Brisbane, brings
together some 500 research staff and
postgraduate students in cellular, develop-
mental, structural, and genomic biology of
human, mouse, and zebrafish, and in
immediately related areas of medicinal
chemistry and preclinical drug develop-
ment. Some 60 of these personnel are
engaged directly in computational molecu-
lar biology and bioinformatics, the largest
Box 1. Authors’ Biographies
Mark Ragan is Professor at The University of Queensland, where he is Head of
Genomics and Computational Biology at the Institute for Molecular Bioscience,
and Adjunct Professor in the School of Information Technology and Electrical
Engineering. He is also Director of the Australian Research Council (ARC) Centre of
Excellence in Bioinformatics. Mark holds a BA in Biochemistry from the University
of Chicago and a PhD in Biology from Dalhousie University. As a researcher with
National Research Council Canada (1978–2000), he helped initiate and develop
programs in bioactive natural products, molecular biology, genomics, and
bioinformatics, including the Sulfolobus solfataricus genome-sequencing project
and Canadian Bioinformatics Resource. Mark was appointed a Fellow of the
Canadian Institute for Advanced Research (1993–2000, relinquished upon his
move to Australia) and is a Fellow of the Linnean Society of London. He served as
co-chair of ISMB-2003 and general chair of APBC-1, and will chair the upcoming
GIW-2008.
Tim Littlejohn is a member of the IBM Healthcare Life Sciences team, and a
member of the IBM Australia Diversity Council. After receiving his PhD in
molecular genetics from the University of Melbourne, Tim served as director of
informatics at the Organelle Genome Sequencing Project in Montre ´al, then
returned to Australia to head the Australian national bioinformatics facility ANGIS.
Tim formed the bioinformatics companies Entigen Inc. in 1998, and BioLateral Pty
Ltd in 2001. He has been actively involved in the Australian bioinformatics and
biotechnology industry for many years, supplying technologies and services to
biotechnologists across Australia and around the world. Tim led the Australian
Federal Government’s Bioinformatics Industry Opportunity Taskforce (2001–2002)
and was co-founder (and is currently President) of the national peak
bioinformatics body Bioinformatics Australia.
Bruce Ross has worked in a variety of roles in biology and computing. He
received a PhD in microbial genetics from the University of Melbourne, then
spent ten years in public health research applying genetics technologies to the
diagnosis and epidemiology of infectious diseases. Thereafter he moved to CSL
Ltd, where he was involved in human vaccine research and development for eight
years. During this time, Bruce led a genome sequencing program designed to
identify vaccine and drug target candidates for a human bacterial pathogen. He
supplemented his biological qualifications with a degree in Software Engineering
from RMIT University, and became leader of the bioinformatics group at CSL. After
this he moved to IBM, where he was responsible for solution architecture and
implementation for life sciences industries for five years, leading the implemen-
tation of a clinical research data repository and a data integration platform based
on the ENSEMBL codebase. In late 2007 Bruce accepted a position at Microsoft
Health Solutions Group.
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encompass the discovery of regulatory
motifs [16] and ncRNAs [17]; computa-
tional analysis of membrane proteins and
intracellular trafficking [18]; modelling
genetic regulatory networks [19] and dy-
namic spatial processes in endosomes and
membranes [20]; comparative genomics
[21]; and transcriptome analysis [22]
including the use of SOLiD sequencing.
IMB also serves as the headquarters of the
AustralianResearch Council (ARC) Centre
of Excellence in Bioinformatics, the
Queensland Facility for Advanced Bioin-
formatics, and the bioinformatics compo-
nent of the Australian Centre for Plant
Functional Genomics (ACPFG) (see Box 3).
The Biosciences Research Centre
(BRC) at Latrobe University, in Mel-
bourne, is a partnership between the
university and the Department of Primary
Industries in the state of Victoria (http://
hornbill.cspp.latrobe.edu.au/). The aims
of BRC are to leverage gene discovery
technologies to identify candidates for
agricultural crop improvement, and to
address strategies for agricultural sustain-
ability in the face of climate change. The
current staffing of more than 100 is
planned to grow to 450, including further
expansion in genomics and bioinformatics.
BRC’s discovery effort is supported by
computational gene annotation and data
integration across ESTs, annotated ge-
nomes, microarrays, genotyping, pheno-
type, and plant breeding experiments.
This centre is, in turn, a partner within
the Victorian Bioinformatics Consortium
(http://www.vicbioinformatics.com/home.
shtml) based at Monash University.
Other major institutes and centres with a
significant computational bioscience profile
include Sydney’s Garvan Institute of Med-
ical Research (specifically the Peter Wills
Bioinformatics Centre: http://linkage.
garvan.unsw.edu.au/bioinformatics/), the
WEHI (microarray statistics, statistical ge-
netics: http://bioinf.wehi.edu.au/), and the
Western Australian Institute of Medical
Research (WAIMR) in Perth (http://
www.amber.org.au/).ResearchatWAIMR
focuses on genetic epidemiology, and re-
searchers there have access to important
cohorts for population genetic data (see
Box 4).
Investment in biomedical bioinfor-
matics continues to grow in Australia.
For instance, in 2006 the Australian
National Health and Medical Research
Council (NHMRC) awarded eight large
grants under its Medical Bioinformatics
Genomics and Proteomics Program in
areas of functional genomics, dendritic
cell heterogeneity profiling, phosphopro-
Box 2. Molecular Medicine Informatics Model
One of the key challenges in realising the human health benefits of genomics and
bioinformatics is to access large amounts of clinical data from well-described
patient cohorts. For genotype association studies to achieve statistical power, and
to reduce the impact of noise created by genomic variation, large numbers of
patients are needed. If thousands or tens of thousands of patients are required,
this cannot be done within the boundaries of a single institution. This philosophy
forms the foundation of the Molecular Medicine Informatics Model (MMIM)
project, which has established a technological and policy framework to enable
hospitals to share de-identified patient data for research purposes (http://www.
mmim.org.au/pages/index.php). MMIM is a collaborative venture between the
Bio21 Institute and Melbourne Health in the state of Victoria. The technology
federates existing data sources across hospitals throughout the state and from
across the country into a single interface. The data are updated daily, and an end-
user can instantly join data from across institutions and databases for cancer,
diabetes, epilepsy, and stroke. The MMIM policy framework provides a common
mechanism to satisfy ethics, privacy, security, and intellectual property. The
project thus provides a data platform for researchers to access and share clinical
and genetic data on patients across institutions to drive advances in our
understanding of human disease processes. —Bruce Ross
Box 3. Computational Biology in ACPFG
The Australian Centre for Plant Functional Genomics (http://www.acpfg.com.au/)
was established in 2003 to provide national capability in cereal genomics. ACPFG
is intended to discover genes and gene systems, develop technologies and access
others from overseas, and deliver to the Australian farming community cereal
varieties with improved tolerance to abiotic stress. ACPFG is headquartered at The
University of Adelaide’s Waite Campus and has research nodes at The University
of Melbourne and The University of Queensland. In total, ACPFG employs more
than 110 staff.
The University of Queensland node is dedicated to bioinformatics development
supporting ACPFG research; the presence of additional support groups at each of
the other nodes ensures tight integration of bioinformatics within research
programs. These bioinformatics groups manage data produced within ACPFG,
provide access to external data, and work with laboratory researchers to develop
novel tools and interfaces for robust analysis.
Plants produce a vast range of primary and secondary metabolites, many of which
have agronomic or medical applications. High-throughput characterisation of
these compounds is being undertaken at the Melbourne node using advanced
mass spectrometry. In support, the Melbourne node is developing custom
databases and tools to store and analyse metabolomic data, and to integrate the
results with data from gene-expression studies at the Adelaide node. Crop
genomes are generally very large, frequently polyploid, and characterised by
abundant repetitive elements, making genome sequencing a major challenge.
Bread wheat, for example, has a hexaploid genome more than five times the size
of the human genome, with the excess due mostly to the expansion of families of
repetitive elements. Research at the Brisbane node has focussed on development
of methods for assembling DNA sequence from Applied Biosystem’s next-
generation SOLiD system, to enable the cost-effective sequencing of large,
complex genomes. Automated sequence annotation pipelines include tools for
the identification of molecular genetic markers that are being applied within
ACPFG to associate genes with important agronomic traits and for marker-
assisted breeding of crop varieties that maintain productivity in an often
unpredictable and harsh environment.
The ACPFG bioinformatics groups work closely with plant phenomic and
metabolomic facilities under NCRIS, the ARC Centre of Excellence in Bioinfor-
matics, and the Queensland Facility for Advanced Bioinformatics. —Dave Edwards,
Head of Bioinformatics, ACPFG
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scans, retroviral expression cloning, and
disease gene mapping in populations
(http://www.nhmrc.gov.au/FUNDING/
funded/outcomes/medbio.htm).
The CSIRO, Australia’s national sci-
ence agency, conducts research in bioin-
formatics and computational bioscience
and applies bioinformatics technologies in
at least eight divisions and centres (Ento-
mology, Food Science, Information and
Communications Technology, Livestock
Industries, Marine and Atmospheric Re-
search, Mathematical and Information
Sciences, Molecular and Health Technol-
ogies, and Plant Industry) around Austra-
lia (see Box 5). A broad range of partner
and internally generated projects include
genome sequencing and annotation, func-
tional and epigenomics, rumen and envi-
ronmental metagenomics, marker-assisted
breeding and trait association, genomic
approaches to disease resistance, desicca-
tion and salinity tolerance, environmental
and climate modelling, and characterisa-
tion of biodiversity.
National ICT Australia (NICTA) was
established in 2002 to conduct and
coordinate aspects of Australia’s research
in information and communications tech-
nologies. With more than AUD 250 mil-
lion in federal government funding plus
significant co-investment, NICTA re-
searchers carry out and collaborate on
research in networks, embedded systems,
data mining, and complexity. Bioscience
and medicine represent significant appli-
cation domains, with NICTA involvement
in automated feature extraction from MRI
scans, body area sensor networks, expres-
sion analysis in cancer detection and
treatment monitoring, large-scale marker-
assisted breeding of crop plants, and
network visualisation (http://www.cs.
usyd.edu.au/,visual/valacon/).
The ARC Centre of Excellence in
Bioinformatics (http://bioinformatics.org.
au/) supports coordinated research pro-
grams in five Australian universities: The
University of Queensland (eight research
groups), The University of Newcastle
(two), Deakin University, Macquarie Uni-
versity, and ANU (one each). The Centre’s
research focuses in four areas: (1) the
Visible Cell project in conjunction with
IMB; (2) inference of pathways and
regulatory networks based on molecular
interaction motifs, gene expression data
and ncRNAs; (3) computational modelling
of dynamic processes in eukaryotic cells
and biomembranes, again in conjunction
with IMB; (4) the development and
application of FPT [23] and metaheuristic
algorithms for very large problems on
graphs and networks. The Centre also
includes three overseas partner institutions
(IBM TJ Watson Research Center, the
University of Auckland, and the University
of Tennessee) and has other active inter-
national research collaborations including
a European supercomputing grid project
(http://www.qoscosgrid.eu/), and a se-
mantic modelling project with Pfizer
Research Technology Center in Cam-
bridge, Massachusetts (http://www.
biomanta.org/).
The Visible Cell project (http://www.
visiblecell.com/) within the ARC Centre
of Excellence in Bioinformatics aims to
inform in silico studies of cell and
molecular organisation in three dimen-
sions, using the mammalian cell as a
unitary example of an ordered complex
system. This unique initiative is based on
whole-cell tomography of serially sec-
tioned cells—at this point the insulin-
producing beta cell—imaged at medium
(15–20 nm) and high (4–5 nm) resolution
Box 4. Joondalup
Human disease is a product of the combination of genetic makeup and
environmental triggers. Most genetic association studies focus on the correlation
of genetics with the disease phenotype after disease manifestation, and take little
account of the factors that predispose disease occurrence or environmental
associations. Longitudinal studies of populations give a long-term, multifactorial
view of humans and disease. In order to address this issue, the Western Australian
Institute for Medical Research (WAIMR) has started the Joondalup Family Health
Study that aims to follow 80,000 citizens every three years in the city of Joondalup
(http://www.jfhs.org.au/). The data collected will comprise comprehensive clinical
and questionnaire data, with an aim to collect 3,000 data points for each three-
year time point. The focus is on families to enable pedigree analytical techniques
to be used as well as population-based genetic association. The project
commenced in late 2007 with the aim of collecting data from 2,000 subjects in
the first instance. —Bruce Ross
Box 5. ’Omics and Bioinformatics in CSIRO
The Commonwealth Scientific and Industrial Research Organisation is Australia’s
national science agency and one of the largest and most diverse research
agencies in the world, with more than 50 sites and 6,500 employees throughout
Australia and overseas. CSIRO has significant bioinformatics activities based in
Mathematical and Information Sciences (CMIS), Livestock Industries (CLI), Plant
Industries (PI), Entomology (CEnto), Ensis (a joint venture with Scion, in
sustainable forest industries), Food Science Australia (FSA) and the Population
Health and Food Futures Flagships. These groups have access to a dedicated
computing array and other shared computational infrastructure. The main areas
of interest include genome sequencing and assembly, miRNomics, gene
expression analysis, whole-genome association analysis from SNPs, and integrat-
ed systems biology analyses. Across CSIRO, groups are involved in genome
projects on cow and sheep (CLI); grape (PI); eucalypt (Ensis); insects, including
honeybee and cotton boll worm (CEnto); large ecogenomics and metagenomics
projects (P-Health, CEnto, CLI); and individual fungi (PI) and bacteria (CLI, FSA). A
large initiative in epigenetic regulation has been funded as part of a cross-CSIRO
Transformational Biology initiative. As part of an Emerging Sciences project,
researchers in PI and CLI are studying the miRNome of a number of plants and
animals. CMIS has developed a novel vertebrate microarray to facilitate
expression analysis for organisms for which the genome has not yet been
sequenced.
With the emergence of large SNP-chips and gene association studies combining
genotyping and phenotyping, substantial work is under way on colorectal cancer
in humans (P-Health) and a range of production and quality phenotypes in cattle
(CLI). Large gene expression analyses and methodology development for datasets
containing more variables than observations (CMIS) are morphing into systems
biology projects with significant projects in colorectal cancer (P-Health), muscle
biology (Food Futures), and inference and visualisation of complex networks
(CMIS). Complementary research is under way in CMIS on the analysis and
extraction of data from complex images of biological samples. —Brian Dalrymple,
Systems and Computational Biology, CLI
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products, molecular interactions, path-
ways, networks, and processes are localised
to the appropriate cellular coordinates via
an ontologically aware semantic querying
interface and federated data supplied by
the Queensland Facility for Advanced
Bioinformatics (see Box 6). The goal is to
‘‘change the way we think about mamma-
lian cells’’ by allowing biologists to visual-
ise genome-scale data, and to model and
simulate molecular processes, not in ab-
stract spatial coordinates but within re-
constructions of actual cells.
At least two other ARC-funded research
centres have significant computational
biology or informatic components. The
ARC Centre of Excellence for Kangaroo
Genomics (ANU, University of Mel-
bourne, University of New South Wales,
WEHI, and AGRF) focuses on compara-
tive genomics and genomic biology of the
tammar wallaby Macropus eugenii. Project
areas include large-scale annotation of
marsupial genomes, curated annotation
of targeted genomic regions (e.g., MHC
and XIST loci), and the development and
application of comparative methods for
the analysis of genomic regions that do not
encode proteins. The ARC Centre of
Excellence in Structural and Functional
Microbial Genomics (http://www.
microbialgenomics.net/), headquartered
at Monash University, applies expression
technology, proteomics, protein crystallog-
raphy, and bioinformatics toward the
understanding of host–pathogen interac-
tions and the development of vaccines and
drugs for selected microbial pathogens
including Burkholderia pseudomallei, Clostridi-
um perfringens, Escherichia coli, and species of
Legionella, Leptospira, and Mycobacterium.
Several research-intensive universities
have established centres of computational
molecular or genomic science. The Centre
for Bioinformation Science, established in
2000 and based in the Mathematical
Sciences Institute at ANU, focuses on
mathematical and statistical aspects of
molecular bioscience including expression
array analysis and molecular evolution
(http://dayhoff.anu.edu.au/). The West-
ern Australia Centre for Comparative
Genomics (CCG) at Murdoch University
was established in 2006, in part as a
continuation of the Centre for Bioinfor-
matics and Biological Computing. CCG
pursues research in human, plants, ani-
mals, pathogens, and bioinformatics, and
hosts the Australian Bioinformatics Facil-
ity established under NCRIS to provide
bioinformatics support for national omics
platforms (see Box 7). The Newcastle
Priority Research Centre for Bioinfor-
matics, Biomarker Discovery, and Infor-
mation-Based Medicine, based at the
Hunter Medical Research Institute and
the nearby University of Newcastle, was
founded in 2006 to develop novel analyt-
ical strategies, particularly based on com-
binatorial optimisation and metaheuristic
algorithms, and to apply high-throughput
genomic and proteomic technologies to-
ward the improvement of clinical out-
comes through individualised treatment
(http://livesite.newcastle.edu.au/cibm).
Sydney Bioinformatics, formed in 2007
through the merger of the Sydney Uni-
versity Biological Informatics and Tech-
nology Centre and ANGIS, carries out
research in theoretical and applied bioin-
formatics and continues the bioinformatics
infrastructure and advanced training ac-
tivities of ANGIS (http://www.usyd.edu.
au/sydneybioinformatics/). At the Univer-
sity of New South Wales, also in Sydney, a
Quantitative and Computational Biology
research grouping focuses mathematical
and modelling techniques on problems in
gene regulation and expression, proteo-
mics, immunology, population genetics,
epidemiology, and viral evolution (http://
www.babs.unsw.edu.au/research/qcb/
index_qcb.html).
Participation in International
Programs
Australian researchers and research
organisations play proactive roles in a
number of international genomics pro-
jects, including the FANTOM3 and FAN-
TOM4 mouse transcriptome projects with
RIKEN Genomic Sciences Centre
[25,26], bovine, sheep, insect, and other
genome projects (see Box 5), marsupial
genomics including the tammar wallaby
project (ARC Centre of Excellence for
Kangaroo Genomics), sponge genomics
[27], the Plasmodium [28] and Trichomonas
genomes [29], and wastewater metage-
nomics [30]. Projects based mostly within
Australia include scabies cDNA sequenc-
ing [31] and developing work on gut
metagenomics.
In late 2007, Australia became an
associate member of the European Mo-
lecular Biology Laboratory (EMBL). Dr
Nadia Rosenthal, Director of the EMBL
outstation in Monterotondo, near Rome
(Italy), is relocating part of her research to
Monash University, in Melbourne, where
Box 6. Queensland Facility for Advanced Bioinformatics
QFAB (http://www.qfab.org/) is a joint initiative of seven institutions and the
Government of Queensland to provide advanced capability and facilities in data
management, integration, and analysis for Australia’s growing biotechnology and
health sectors. Founded in early 2007, QFAB is providing high-end data
integration and analysis for its partners and a growing base of clients. Its
partners are The University of Queensland (UQ), Queensland University of
Technology (QUT), Griffith University, eHealth Research Centre (a joint venture of
CSIRO and Queensland Government), Queensland Department of Primary
Industries and Fisheries (QDPI&F), Queensland Cyber Infrastructure Facility, and
the Australian Partnership in Advanced Computing (the latter now incorporated
into NCRIS). Partner contributions often leverage other initiatives, including the
ARC Centre of Excellence in Bioinformatics at UQ, the Microsoft QUT eResearch
Centre, and the QDPI&F Agricultural Biotechnology Centre.
QFAB’s partners provide tools, workflow technology, health data integration
software, computational resources, and ICT experience. QFAB operates mirrors of
the UCSC Genome Browser and ENSEMBL, and hosts public and proprietary
datasets federated via SRS. With transparent access to data and applications via
Storage Resource Broker, project-dedicated computation and storage, and the
security of shibboleth, certificates and keys, partners and clients carry out secure
in silico discovery both onsite and remotely.
QFAB has delivered an initial solution to the challenge faced by the KOALA
Childhood Obesity Project (http://koala.imb.uq.edu.au/) in capturing data from
participating families and researchers, and continues to work with the project
toward its goal of identifying biomarkers for the future onset of obesity-related
illnesses. QFAB is providing the informatics for a large five-year project on nuclear
receptors in breast cancer, led by the Westmead Research Institute in Sydney and
supported by the National Breast Cancer Foundation. For key data-integration
and collaboration components of the latter project, QFAB is working in
partnership with a national e-research project (http://www.archer.edu.au/)
recently subsumed under NCRIS. —Jeremy Barker, CEO QFAB
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erative Medicine Institute. Other new
initiatives, including Australia-funded
group leaders in Europe and EMBL
laboratories in Australia, will be coordi-
nated through the new body EMBL
Australia. The founding members of
EMBL Australia are CSIRO, four re-
search-intensive universities (Monash,
Queensland, Sydney, and Western Aus-
tralia), and the federal government
through NCRIS.
Modelled after EMBL, the electronic
International Molecular Biology Labora-
tory (eIMBL) is a Korean initiative with
virtual research groupings or study groups
in six areas (http://www.eimbl.org/). The
most active of these, in Systems Biology,
links systems researchers in ten countries,
including one group in Australia (at IMB).
eIMBL emphasises the training of young
researchers, exchange of knowledge and
resources, and collaboration in systems
biology research using Web/grid infra-
structure.
Australia has hosted important interna-
tional conferences in computational biol-
ogy and bioinformatics including the
inaugural Asia-Pacific Bioinformatics
Conference (APBC-2003) in Adelaide,
the 11
th International Conference on
Intelligent Systems in Molecular Biology
(ISMB-2003) in Brisbane, and the inaugu-
ral Computational Models for Life Sci-
ences (CMLS’07) on the Gold Coast. The
19
th International Conference on Genome
Informatics (GIW-2008) will be held on
the Gold Coast in early December 2008.
Computational biology is increasingly
finding a place in other international
events in Australia, including conferences
in genomics, high-performance and grid
computing, and e-research.
Infrastructure, Education,
Training, and Career
Development
As described above, the 2005 national
bioinformatics strategy [13] made recom-
mendations in several areas including
infrastructure. During 2007, Bioinfor-
matics Australia (BA), the national peak
body in bioinformatics (see Coordination,
below), conducted extensive face-to-face
consultation in five cities to assess infra-
structure needs in detail. These needs fell
into three areas: (1) hard infrastructure
(computing hardware and networks); (2)
soft infrastructure (software tools, data
mirrors, data-exchange formats); (3) hu-
man infrastructure (people skilled in var-
ious bioinformatics areas), with the latter
identified as the most pressing issue. To
the extent that hard or soft infrastructure
was underutilised or did not fully address
the needs of the biosciences R&D com-
munity, this was invariably seen to be due
to limitations on human expertise, not on
the hard or soft infrastructure components
per se. These human infrastructure needs
can be addressed via education and
training. Three levels of education and
training need were identified: (1) under-
graduate education in a core area such as
molecular bioscience, computer science,
or information technology, with supple-
mentary work in the cognate disciplines;
(2) postgraduate education including cour-
sework as well as research; (3) short
courses to up-skill researchers from both
life sciences and informatics backgrounds.
As many as 14 Australian universities
offer undergraduate degree programs or
streams in computational biology and/or
bioinformatics ([32], updates on http://
www.ausbiotech.org/bioinformatics, http:
//www.nslij-genetics.org/bioinfotraining/,
and elsewhere). A level of dynamism is
expected in any competitive field, but
Australian tertiary education programs
are currently unusually dynamic. The
University of Melbourne (http://www.
futurestudents.unimelb.edu.au/about/m_
model/index.html) is replacing its nearly
100 existing undergraduate degrees with a
US-style three-year Bachelors in one of six
broad areas (e.g., Science) followed by
specialised Masters or PhD training.
Several other research-intensive universi-
ties are either considering this model, or
consolidating degree programs without
Box 7. Australian Bioinformatics Facility
The Australian Bioinformatics Facility (ABF) supports the Australian Government’s
AUD 50 million investment in ‘‘omics’’ and bioinformatics through the National
Collaborative Research Infrastructure Scheme (NCRIS). ABF delivers leading-edge
bioinformatics infrastructure and services to build bioinformatics service capacity
within and across the three national omics platforms (genomics, proteomics, and
metabolomics). ABF supports these platforms in three main ways:
N Working in collaboration with the platforms, ABF will embed bioinformaticians
in the platform nodes at locations across Australia. These embedded
bioinformaticians will support existing bioinformatics staff in the nodes and
will work across a myriad of platform-specific projects.
N From its Perth base, ABF will provide direct (non-embedded) bioinformatics
support to platform staff across a range of projects agreed between the
platforms and ABF. These non-embedded staff will facilitate cross-platform
initiatives to minimise duplication and maximise output associated with the
bioinformatics investment.
N Through linkages with bioinformatics facilities nationally and internationally,
ABF will disseminate best practice to platforms to enhance their bioinformatics
service capacity.
ABF is a specialised service platform operating within CCG and drawing on its full
range of expertise and infrastructure. CCG (http://ccg.murdoch.edu.au/index.php/
Main_Page) represents a unique approach to research in comparative genomics,
drawing together biomedical and agricultural research and development,
bioinformatics activities, and expertise in comparative genomics to promote
shared understanding within and across fields of study.
The CCG team has expertise in bioinformatics, computational biology,
comparative genomics, molecular biology, Internet-based software development,
and high-performance computing. Specific bioinformatics capabilities include
sequence assembly, gene and genome annotation, mapping, transcriptomics,
comparative genomics, vaccine candidate identification, new tools for alignment,
phylogenetic analysis, gene expression and statistical analysis, peptide mass
fingerprinting analysis, and customisation of protein datasets. At the heart of CCG
is the Bioinformatics Research Laboratory (BRL), which supports academic and
industry researchers with a range of capabilities including the development of
computational tools, data analysis and high-resolution visualisation strategies,
and integrated Web-based applications. BRL is a dedicated high-performance
computing facility that will soon be upgraded to 500+ cores. A key feature is a
463 m, 18 million pixel high-resolution display wall. BRL also provides industry
and scientists access to state-of-the-art computing infrastructure and support. —
Matthew Bellgard, Convenor of the Australian Bioinformatics Facility, and Director of
CCG
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quence, courses in computational molec-
ular biology and bioinformatics could be
developed at the postgraduate, not under-
graduate, level. Already the market de-
mand is greater for graduates with PhD
and MSc degrees in these areas than for
undergraduate degree-holders. Market
demand extends across software develop-
ment, data management, statistics, and life
sciences and health application domains.
Despite the market demand for skilled
bioinformaticians and the availability of
diverse educational programs (mostly at
the undergraduate level), uptake by stu-
dents is currently low. The lack of clear
career paths in bioinformatics was identi-
fied as the most likely reason for this
mismatch between supply and demand.
The BA survey found a substantial
degree of satisfaction with the (mostly)
generic personnel support that has been
provided by national hard-infrastructure
facilities such as APAC. As data manage-
ment and interpretation challenges in-
crease, however, there may be scope for
more-specialised facilities such as Queens-
land Facility for Advanced Bioinformatics
(QFAB) (Box 6) that provide a customised,
integrated approach to hard infrastruc-
ture, software, and human expertise. BA
also heard concerns that many integrated
bioinformatics software packages require
specialised skills; facilities such as ANGIS
remain popular because they provide and
maintain user-friendly environments such
as the Web-based BioManager bioinfor-
matics system.
Professional bioinformatics training re-
mains in demand in Australia. The
Ludwig Institute for Cancer Research, in
Melbourne, has run a bioinformatics
training course since 1998. A week-long
‘‘BioInfoSummer’’ workshop, held annu-
ally since 2003 at ANU in Canberra,
presents topics in bioinformatics to stu-
dents and researchers from diverse back-
grounds. The one-week Winter School in
Mathematical and Computational Biolo-
gy, organised in late June or early July
since 2004 by the ARC Centre of
Excellence in Bioinformatics, covers areas
beyond bioinformatics per se, including
algorithmics, computational neuroscience,
and e-research. Each of the latter two
advanced schools typically attracts 150–
200 participants. ANGIS has offered
training courses in the use of bioinfor-
matics tools across Australia, throughout
the year, since its inception in 1990.
The spread of high-throughput ‘‘omic’’
technologies, including next-generation
DNA sequencing, various array platforms,
metabolomics, and mutagenesis screens in
zebrafish or mouse is already placing new
demands on human infrastructure, some
but not all of which are being addressed
within NCRIS (above). In part through
NCRIS, the Australian government is
taking a coordinated national approach
to management of the research data
lifecycle, including capture, interopera-
tion, access, and support for collaboration,
with explicit recognition of the key role of
expert human infrastructure.
Commercial Activity
Australia is home to some 427 biotech-
nology companies [33] of which 49% are
involved in human therapeutics, 16% in
agricultural biotech, and 13% in diagnos-
tics; these numbers exclude the 625
companies that focus on medical devices.
Several of these companies have signifi-
cant positions in computational biology,
computational chemistry, bioinformatics,
or statistical genetics. Catapult Genetics
(http://www.catapultgenetics.com/), re-
cently formed by the merger of the
Brisbane-based Genetic Solutions with
New Zealand-based Catapult Systems,
develops DNA markers and other molec-
ular and informatic technologies for prod-
uct identification, validation, traceability,
quality enhancement, and production
efficiency in cattle and sheep. ChemGenex
Pharmaceuticals (http://www.chemgenex.
com), based in Geelong (near Melbourne),
uses genotyping of disease pedigree co-
horts to identify genomic regions associat-
ed with diabetes and obesity; after fine-
scale mapping and gene identification,
validation is carried out in animal models.
Nucleics (http://www.nucleics.com/),
based in Bendigo (also near Melbourne),
conducts research on new technologies for
DNA sequencing and epigenomics, in-
cluding software and bioinformatics. Syd-
ney-based Proteome Systems (http://
www.proteomesystems.com/) develops
protein biomarkers associated with diseas-
es with focus on tuberculosis, prostate
cancer, and Huntington Disease, and
following the acquisition of a US company
have a portfolio of small molecule drug
candidates, some of which are in clinical
trials. The well-regarded BioinformatiQ
software suite for proteomics was devel-
oped by Proteome Systems. In addition,
many global pharmaceutical firms, such as
Johnson & Johnson Research (http://
www.johnsonandjohnson.com.au), have a
strong computational or informatic R&D
presence in Australia.
The business case in bioinformatics per
se is (as elsewhere internationally) more
challenging. Early companies included
eBioinformatics, a startup spun out from
The University of Sydney, and BioLateral,
followed later by CSIRO Bioinformatics, a
wholly owned subsidiary of CSIRO, and
the privately held Emphron Informatics
(http://www.emphron.com) in Brisbane.
Coordination
The national peak bioinformatics body
in Australia is BA. BA was formed in 2004
by the merger of the Association of
Australian Bioinformatics (AAB), an aca-
demic-based society, with the Bioinfor-
matics Special Interest Group within
AusBiotech (the national biotechnology
peak body). BA is legally a subentity of
AusBiotech (http://www.ausbiotech.org/)
but operates in many regards as an
independent entity; decisions for BA are
made by a Management Committee of
seven members elected by the BA mem-
bership plus two appointed by AusBiotech.
Decisions involving a direct and specific
financial or contractual commitment must
be ratified by AusBiotech before they can
be actioned. Two of the authors (TL and
MAR) are BA president and vice-presi-
dent, respectively. Each of BA’s first two
annual conferences (Sydney 2006 and
Brisbane 2007) attracted 100–110 partic-
ipants. The 2008 BA conference will be
combined with the International Confer-
ence on Genome Informatics (GIW-2008),
which will be held on the Gold Coast from
1–3 December 2008.
One of the outcomes of the 2005
bioinformatics strategy [13] was federal
funding for an Australian Bioinformatics
Network (2006–2007) managed by BA.
This allowed BA to appoint a coordinator,
conduct a nationwide survey of needs and
concerns among the bioinformatics R&D
community (see Infrastructure, Education,
Training, and Career Development,
above), and establish a Web site (http://
www.ausbiotech.org/content.asp?pageid=
77).
BA (in its earlier incarnation as AAB)
was a founding partner within the Associ-
ation of Asian Societies of Bioinformatics
(AASBi), a voluntary partnership among
bioinformatics societies in Japan, South
Korea, Singapore, Taiwan, and Australia.
AASBi has taken responsibility for the
annual International Genome Informatics
Conference (GIW) and will develop other
initiatives in the region.
Envoi
Set against the previous review in 2000
[1], the landscape of computational biol-
ogy and bioinformatics in Australia has
evolved almost (but not quite) beyond
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rived, although program continuity re-
mains an issue, and the Australian com-
munity lacks a common institutional base
comparable to EBI or NCBI. Nonetheless,
much high-quality research, both funda-
mental and applied, is under way, and
bioinformatics has been recognised [34] as
an area of emerging strength critical to the
country’s established life sciences and
medical sectors. Recommendations in the
national bioinformatics strategy have been
refined via the Australian Bioinformatics
Network managed by the new national
peak body, Bioinformatics Australia. Insti-
tutions across the country offer a range of
undergraduate and postgraduate educa-
tional opportunities. Hard and soft infra-
structure is adequate, but ongoing com-
mitment will be required to support next-
generation sequencing and systems biolo-
gy. More remains to be done in advanced
training, the development of human
expertise, and the clarification of career
paths. Through NCRIS and associated
initiatives, Australia is showing leadership
in the development and implementation of
coordinated national systems for integrat-
ed access, high-performance computing,
and end-to-end management of the data
lifecycle. Many international links are in
place (with more under development), and
the commercial sector—which has much
to benefit from growth and consolidation
of computational biology and bioinfor-
matics—is supportive. Community-build-
ing is under way on numerous fronts.
Although much remains to be done,
genome-scale computational biology and
bioinformatics in Australia is on a very
promising trajectory.
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